Alicia Barber is a Neuroscience PhD candidate at Dartmouth focused on therapeutic and biomarker development for Alzheimer’s disease with the goal of advancing precision medicine applications in dementia care. Alicia earned a Master of Philosophy in Translational Biomedical Research from the University of Cambridge in 2018, where she was rigorously trained in clinical trial design, drug development, and rare disease studies.